Designing simpler natural-product medicines to uncover how they work
Pharmacophore - Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies
['FUNDING_OTHER'] · BAYLOR UNIVERSITY · NIH-11252530
Researchers are creating simplified versions of complex natural compounds to find new medicines that might help people with cancer, immune disorders, stroke-related injury, or bacterial infections.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BAYLOR UNIVERSITY (nih funded) |
| Locations | 1 site (WACO, UNITED STATES) |
| Trial ID | NIH-11252530 on ClinicalTrials.gov |
What this research studies
This project focuses on making simpler, easier-to-produce versions of complex natural substances that have shown activity against cancer, immune problems, ischemic (stroke) damage, or bacteria. Scientists will design molecules around proposed 'pharmacophores' and carry out stepwise chemical synthesis while testing biological activity at multiple stages. By collecting structure–activity information during synthesis, they hope to spot promising compounds early and refine designs more quickly. Promising candidates will be tested in laboratory assays and likely in animal models to learn how they work and whether they could become drug leads.
Who could benefit from this research
Good fit: People with cancer, certain immune disorders, ischemic stroke, or serious bacterial infections could be potential future trial candidates or sample donors for related follow-up studies.
Not a fit: Patients seeking immediate treatment benefit should not expect direct help now because this is primarily laboratory and preclinical chemistry and biology work.
Why it matters
Potential benefit: If successful, the work could produce simpler, more accessible drug candidates or research tools that target cancer, immune diseases, stroke damage, or bacterial infections.
How similar studies have performed: Related efforts to simplify natural products have sometimes produced useful drug leads and research tools, and this pharmacophore-directed approach builds on those concepts while being a newer, more systematic strategy.
Where this research is happening
WACO, UNITED STATES
- BAYLOR UNIVERSITY — WACO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROMO, DANIEL — BAYLOR UNIVERSITY
- Study coordinator: ROMO, DANIEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers